Navigation Links
Anesiva Initiates Phase 2 Trial with Adlea(TM) for Pain Relief Following Total Hip Replacement Surgery
Date:10/4/2007

lation on the first post-operative day and significantly less pain on follow-up visits at two weeks. Adlea-treated patients also had numerically lower mean pain scores at pre-specified time intervals over the first two weeks post-surgery in the study while pharmacokinetic data demonstrated that most patients (19 of 25) had detectable plasma Adlea levels for less than 12 hours (presented at the American Pain Society meeting in May 2007). This short duration of systemic exposure associated with the long duration of pain relief following a single Adlea dose may potentially represent a huge advantage in risk-benefit ratio with Adlea use relative to the conventional systemically active analgesics on the market. As expected, the study also met its primary objective of demonstrating safety and tolerability.

Anesiva's goal is to initiate clinical trials of Adlea for two lead indications in the coming months: management of acute post-operative pain associated with orthopedic surgeries and management of osteoarthritis pain in the knee. These include a Phase 2 trial in arthroscopic shoulder surgery, a Phase 2 / 3 trial in osteoarthritis of the knee, and a Phase 3 trial in Total Knee Arthroplasty (TKA). Anesiva also recently initiated a Phase 2 trial in TKA.

How Adlea May Address The Need for Long-Duration, Well-Tolerated Pain Relief

Adlea is long-acting, with the potential to provide pain relief for weeks or months after just a single localized treatment. It is a non-opioid TRPV1 agonist with a unique mechanism of action that provides a long-lasting, localized effect on C-fibers and blocks the transmission of aching, throbbing pain caused by major surgical procedures and end-stage osteoarthritis. Because it selectively acts on pain-sensing nerve endings, Adlea does not affect other nerve fibers necessary for sensory or motor sensations and proprioception.

Pharmacokinetic studies of Adlea showed that when it is locally administered to the site of pain, t
'/>"/>

SOURCE Anesiva, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Anesiva Announces Phase 2 Data Showing Substantial, Long-Term Pain Reductions with Adlea(TM) (formerly 4975) in Osteoarthritis of the Knee
2. Malvern initiates European user group meetings for chemical imaging
3. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
4. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
5. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
8. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
11. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... July 29, 2015  Shareholder rights law firm ... certain officers and directors of AMAG Pharmaceuticals, Inc. ... AMAG Pharmaceuticals operates as a specialty pharmaceutical company ... supportive care.  The company markets Makena, a hydroxyprogesterone ... birth in women with a singleton pregnancy. ...
(Date:7/29/2015)... LOVELAND, Colo., July 29, 2015 Heska Corporation ... "Company"), a provider of advanced veterinary diagnostic and other ... second quarter ended June 30, 2015. Second ... from Operations was up nearly 100% to $1.829 million, from ... 29% to $10.1 million, from $7.8 million. , Core ...
(Date:7/29/2015)... The Judicial Panel on Multidistrict Litigation (JPML) will hear ... vena cava (IVC) Filter lawsuits filed against C.R. Bard.  ... been centralized by the JPML. "IVC filters ... a pulmonary embolism. The filters are designed to prevent ... Bard and Cook involve incidents of retrievable IVC filters ...
Breaking Medicine Technology:Robbins Arroyo LLP Is Investigating the Officers and Directors of AMAG Pharmaceuticals, Inc. (AMAG) on Behalf of Shareholders 2Heska Reports Financial Results for the Second Quarter of 2015 2Heska Reports Financial Results for the Second Quarter of 2015 3Heska Reports Financial Results for the Second Quarter of 2015 4Heska Reports Financial Results for the Second Quarter of 2015 5Heska Reports Financial Results for the Second Quarter of 2015 6Heska Reports Financial Results for the Second Quarter of 2015 7Heska Reports Financial Results for the Second Quarter of 2015 8IVC filter litigation continues; law firm provides free information to IVC filter patients 2
... leading biopharmaceutical company committed to the development of new ... key sets of Vimpat® (lacosamide) C-V data at the ... in Baltimore, Md., December 2-6.  "At ... lives of people living with epilepsy," said Dr. James ...
... 2011   Octapharma USA announced that octagam ® ... for purchase. The U.S. Food and Drug Administration (FDA) ... ® 5% , a therapy to treat disorders of the ... In August 2010, Octapharma initiated a voluntary ...
Cached Medicine Technology:New Data on Vimpat® (lacosamide) C-V to Be Presented at the 65th Annual Meeting of the American Epilepsy Society 2New Data on Vimpat® (lacosamide) C-V to Be Presented at the 65th Annual Meeting of the American Epilepsy Society 3New Data on Vimpat® (lacosamide) C-V to Be Presented at the 65th Annual Meeting of the American Epilepsy Society 4New Data on Vimpat® (lacosamide) C-V to Be Presented at the 65th Annual Meeting of the American Epilepsy Society 5New Data on Vimpat® (lacosamide) C-V to Be Presented at the 65th Annual Meeting of the American Epilepsy Society 6New Data on Vimpat® (lacosamide) C-V to Be Presented at the 65th Annual Meeting of the American Epilepsy Society 7Octapharma Announces octagam® 5% Again Available for U.S. Purchase 2Octapharma Announces octagam® 5% Again Available for U.S. Purchase 3Octapharma Announces octagam® 5% Again Available for U.S. Purchase 4Octapharma Announces octagam® 5% Again Available for U.S. Purchase 5
(Date:7/29/2015)... ... July 29, 2015 , ... Potomac Pilates, an elite ... its name to Rock the Reformer ® by Potomac Pilates. On Thursday, July ... . Rock the Reformer ® by Potomac Pilates will continue to offer the same ...
(Date:7/29/2015)... ... July 29, 2015 , ... Join Luz Delia Gerber and Abbi ... that Well-Being begins with understanding how the body actually works. A state of mindfulness ... Guests will receive tips on how to forge this new relationship with their bodies. ...
(Date:7/29/2015)... ... July 29, 2015 , ... More than 28,000 ... providers of children living with autism will converge upon Penn State to share ... , The National Autism Conference will be held Aug. 3-6 at the Penn ...
(Date:7/29/2015)... ... 29, 2015 , ... The healthcare analytics market is categorized ... Factors such as the rising pressure to curb healthcare costs, big data in ... capital investments are driving market growth. Check 149 data tables & 57 figures ...
(Date:7/29/2015)... LAUREL, NJ (PRWEB) , ... July 29, 2015 ... ... Certification’s (the Commission) CCM® credential for a five-year period, expiring November 30, 2019, ... its CCM credential by submitting an application demonstrating the program’s compliance with the ...
Breaking Medicine News(10 mins):Health News:Same Great Pilates Studio, New Brand - Rock the Reformer 2Health News:Pampering and Empowerment Abound at Final Event in Luz Delia Gerber’s Book Unveiling 2Health News:Penn State Conference to Address Instruction, Success for Children with Autism 2Health News:Healthcare Analytics Market Growing at 26.5% CAGR to 2020 2Health News:Healthcare Analytics Market Growing at 26.5% CAGR to 2020 3Health News:Healthcare Analytics Market Growing at 26.5% CAGR to 2020 4Health News:Healthcare Analytics Market Growing at 26.5% CAGR to 2020 5Health News:Commission for Case Manager Certification Receives Re-Accreditation of its CCM® credential from the National Commission for Certifying Agencies (NCCA) 2Health News:Commission for Case Manager Certification Receives Re-Accreditation of its CCM® credential from the National Commission for Certifying Agencies (NCCA) 3
... surgery that leaves no scars has become the ... surgeons. Since conventional open surgery gave way to ... 5 incisions, surgeons operating on the pelvic and ... investigating new ways of entering the body to ...
... and Penn Avenue Place buildings, as well as Camp ... participating in Earth Hour on March 28 PITTSBURGH, March ... its energy conservation efforts in 2008, such as the ... and heating and air conditioning usage, resulted in an ...
... Ways for Physicians to Electronically Receive and Transmit ... Connections Across AmericaCARROLLTON, Ga., March 12 Greenway ... of Prime Exchange (R) , the company,s ... electronically shared between physicians and care facilities within ...
... for AARP , , WASHINGTON, March 12 ... A. Barry Rand, known for being a catalyst for ... CEO in early April succeeding Bill Novelli, who has ... be the first African-American to lead the organization.(Logo: ...
... enhances speed and accuracy of patient orders through ... plan and medical conditionRICHMOND, Va., March 12 ... of billable home medical supplies, announced the launch ... enhance speed and accuracy of patient medical supply ...
... PhD, is frequent presenter on the causes of failed ... methods for improvementHAMILTON, N.J., March 12 MedAvante, Inc. ... that Michael Detke, MD, PhD, has joined the company ... Research Institute. Dr. Detke comes to MedAvante from Eli ...
Cached Medicine News:Health News:The navel: A single, safe surgical access route for kidney extraction 2Health News:The navel: A single, safe surgical access route for kidney extraction 3Health News:Highmark Facilities Reduced Energy Consumption by 5.6 Percent in 2008 2Health News:Highmark Facilities Reduced Energy Consumption by 5.6 Percent in 2008 3Health News:Greenway Medical Technologies' Interoperability Engine, PrimeExchange, Allows Physicians to Securely Share Patient Data Amongst Wide Range of Providers in Patient's Care Continuum 2Health News:Greenway Medical Technologies' Interoperability Engine, PrimeExchange, Allows Physicians to Securely Share Patient Data Amongst Wide Range of Providers in Patient's Care Continuum 3Health News:Greenway Medical Technologies' Interoperability Engine, PrimeExchange, Allows Physicians to Securely Share Patient Data Amongst Wide Range of Providers in Patient's Care Continuum 4Health News:Greenway Medical Technologies' Interoperability Engine, PrimeExchange, Allows Physicians to Securely Share Patient Data Amongst Wide Range of Providers in Patient's Care Continuum 5Health News:Agent for Social Change to Lead Nation's Largest Membership Organization 2Health News:Agent for Social Change to Lead Nation's Largest Membership Organization 3Health News:Agent for Social Change to Lead Nation's Largest Membership Organization 4Health News:Home Care Delivered, Inc. Launches Proprietary Insurance Payer Management System 2Health News:Detke Joins MedAvante as Chief Medical Officer 2Health News:Detke Joins MedAvante as Chief Medical Officer 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: